l e t t e r s 9 3 2 VOLUME 21 | NUMBER 8 | AUGUST 2015 nature medicine Aging drives cognitive and regenerative impairments in the adult brain, increasing susceptibility to neurodegenerative disorders in healthy individuals [1] [2] [3] [4] . Experiments using heterochronic parabiosis, in which the circulatory systems of young and old animals are joined, indicate that circulating pro-aging factors in old blood drive aging phenotypes in the brain 5, 6 . Here we identify 2-microglobulin (B2M), a component of major histocompatibility complex class 1 (MHC I) molecules, as a circulating factor that negatively regulates cognitive and regenerative function in the adult hippocampus in an age-dependent manner. B2M is elevated in the blood of aging humans and mice, and it is increased within the hippocampus of aged mice and young heterochronic parabionts. Exogenous B2M injected systemically, or locally in the hippocampus, impairs hippocampal-dependent cognitive function and neurogenesis in young mice. The negative effects of B2M and heterochronic parabiosis are, in part, mitigated in the hippocampus of young transporter associated with antigen processing 1 (Tap1)-deficient mice with reduced cell surface expression of MHC I. The absence of endogenous B2M expression abrogates age-related cognitive decline and enhances neurogenesis in aged mice. Our data indicate that systemic B2M accumulation in aging blood promotes age-related cognitive dysfunction and impairs neurogenesis, in part via MHC I, suggesting that B2M may be targeted therapeutically in old age.
increase in the concentration of B2M in plasma derived from aged (18 and 24 months) compared to young (3 months) mice (Fig. 1a) , and in plasma derived from young (3 months) heterochronic parabionts after exposure to aged (18 months) blood compared to age-matched young isochronic parabionts (Fig. 1b) . Additionally, we detected an age-related increase in the concentration of B2M measured in archived plasma and cerebrospinal fluid (CSF) samples from healthy individuals between 20 and 90 years of age (Fig. 1c,d and Supplementary Table 1) .
Next we tested whether increasing B2M systemically could elicit cognitive impairments reminiscent of age-related dysfunction. As a control, we assessed hippocampal-dependent learning and memory using radial arm water maze (RAWM) and contextual fear conditioning paradigms in a cohort of young (3 months) and aged (18 months) untreated mice and observed age-related cognitive impairments ( Supplementary Fig. 1 ). Subsequently, we tested cognitive function in young (3 months) mice systemically administered soluble B2M protein (100 µg/kg) or vehicle (PBS) via intraorbital injections five times over 12 d (Fig. 1e) . Animals showed no signs of illness or weight loss regardless of treatment (Supplementary Fig. 2a) . During RAWM training, all mice showed similar swim speeds (Supplementary Fig. 2b ) and learning capacity for the task (Fig. 1e) . However, during testing, animals receiving B2M exhibited impaired learning and memory, committing more errors in locating the target platform than animals receiving vehicle control (Fig. 1e) . During fear conditioning training, all mice showed no differences in baseline freezing time (Supplementary Fig. 2c ). However, mice receiving B2M demonstrated decreased freezing time during contextual (Fig. 1e) , but not cued (Supplementary Fig. 2d ), memory testing as compared to vehicle-treated control animals.
Impairments in hippocampal-dependent learning and memory have been previously linked with decreased adult neurogenesis [26] [27] [28] . Although a causal link between age-related cognitive decline and decreased adult neurogenesis remains obfuscated [29] [30] [31] [32] , recent studies using heterochronic parabiosis indicate that cognitive changes elicited by blood from aged rodents are associated with corresponding changes in adult neurogenesis 5, 6 . Consequently, we investigated whether increased systemic exposure to B2M decreased adult hippocampal neurogenesis. By using immunohistochemical analysis, we detected a significant decrease in the number of doublecortin (DCX)-positive newly born neurons (Fig. 1f,g ), nestin-positive progenitors ( Supplementary Fig. 3a) , minichromosome maintenance type 2 (MCM2)-positive progenitors (Supplementary Fig. 3b) , and proliferating cells having incorporated bromodeoxyuridine (BrdU; Supplementary Fig. 3c ) in the dentate gyrus (DG) of mice that were systemically administered exogenous B2M via intraorbital injections, as compared to mice injected with vehicle control. As a negative control, we previously demonstrated that systemic administration of monocyte colony-stimulating factor (M-CSF), a protein that is not altered in plasma with age, does not elicit changes in adult neurogenesis 6 .
To determine whether systemic age-related changes in B2M levels were also accompanied by local changes within the brain, we measured B2M levels within the hippocampus of young (3 months) and aged (18 months) animals by western blot analysis, and we detected an age-related increase in B2M protein expression (Fig. 2a) . Similarly, npg we found that systemic changes in the levels of B2M, elicited by exposure to an aged (18 months) systemic environment, were also associated with a corresponding increase in B2M protein expression in the hippocampal lysates of young (3 months) heterochronic parabionts versus age-matched young isochronic parabionts (Fig. 2b) .
To test the effect of local exposure to exogenous B2M on learning and memory, we administered a single dose of B2M or vehicle to young (3 months) mice by bilateral stereotaxic injection that was followed 6 d later by cognitive testing with RAWM and contextual fear conditioning (Fig. 2c) . All mice showed similar swim speeds (Supplementary Fig. 4a ) and learning capacity (Fig. 2c) during RAWM training. During testing, animals that received B2M committed more errors in locating the target platform than animals receiving vehicle control (Fig. 2c) . During fear conditioning training, no mice exhibited differences in baseline freezing time ( Supplementary  Fig. 4b ). However, mice that received B2M demonstrated decreased freezing time during contextual (Fig. 2c) , but not cued ( Supplementary  Fig. 4c ), memory testing. To investigate how persistent the effects of B2M are on cognitive function, we administered a single dose of B2M or vehicle to an independent cohort of young (3 months) mice by bilateral stereotaxic injections; this was followed 30 d later by cognitive testing with RAWM and contextual fear conditioning (Fig. 2d) . Impairments in hippocampal-dependent learning and memory after local B2M administration were no longer apparent npg after this extended recovery period ( Fig. 2d and Supplementary  Fig. 4d-f ), indicating that the negative effects of B2M on cognitive function are not sustained and potentially reversible. Given that B2M is an active component of the MHC I complex through non-covalent interactions on the cell surface, we investigated whether surface MHC I expression mediates the negative effects of exogenous B2M on cognitive function. The TAP1 protein is required for transport of MHC I molecules, and the absence of TAP1 results in very few classical MHC I molecules reaching the cell surface 16, 17, 33 . Therefore, we administered B2M or vehicle control to young (3 months) Tap1-knockout mice (Tap1 −/− ) by bilateral stereotaxic injections that were followed 6 d later by cognitive testing with RAWM and contextual fear conditioning (Fig. 2e) . Local administration of B2M did not alter hippocampal-dependent learning and memory in Tap1 −/− as compared to vehicle-injected Tap1 −/− mice ( Fig. 2e and Supplementary Fig. 5 ). Consistent with previous reports 34 , we observed no differences in learning and memory between young Tap1 −/− mice and their wild-type (WT) littermates ( Supplementary Fig. 6 ).
To examine the effect of local exposure to exogenous B2M in the brain, we stereotaxically injected B2M into the right DG and vehicle control into the left contralateral DG of young (3 months) mice (Fig. 2f) . Local exposure of the DG to B2M resulted in a decrease in the number of DCX-positive newly born neurons (Fig. 2g,h ), nestinpositive progenitors ( Supplementary Fig. 7a ), and eomesodermin homolog (TBR2)-positive progenitors (Supplementary Fig. 7b ), as compared with what we observed in the contralateral DG treated with vehicle control. Additionally, we investigated the effects of B2M in vitro. Exposure of primary mouse hippocampal neural progenitor cells (NPCs) to soluble B2M resulted in decreased self-renewal, proliferation, and neuronal differentiation in the absence of cytotoxicity (Supplementary Fig. 8 ).
To test whether decreased surface MHC I expression could also mitigate the inhibitory effect of exogenous B2M at a cellular level, we stereotaxically injected young (3 months) Tap1 −/− mice with B2M into the right DG, and we injected vehicle control into the left contralateral DG (Fig. 2f) . We detected no difference in the number of DCX-positive (Fig. 2g,i) , nestin-positive ( Supplementary  Fig. 9a ), or TBR2-positive (Supplementary Fig. 9b ) cells between the B2M-treated DG and the control-treated DG of Tap1 −/− mice.
Consistent with previous reports 34 , we observed no differences in baseline levels of neurogenesis between young Tap1 −/− mice and their WT littermates (Supplementary Fig. 10 ). Additionally, in vitro, we observed no changes in self-renewal after exposure to B2M in primary mouse hippocampal NPCs derived from Tap1 −/− mice (Supplementary Fig. 8h) .
Next, we sought to investigate whether decreasing surface MHC I expression could also mitigate, in part, the negative effects of aged blood on adult neurogenesis elicited by heterochronic parabiosis (Fig. 3a) . Consistent with previous reports 5, 6 , we observed a decrease in the number of DCX-positive immature neurons (Fig. 3b,c) , TBR2-positive progenitors (Supplementary Fig. 11) , and BrdU-positive proliferating cells (Fig. 3d) in young (3 months) WT heterochronic parabionts (exposed to an aged circulation) versus age-matched young WT isochronic parabionts. In contrast, there was no significant difference in the levels of neurogenesis in young (3 months) Tap1 −/− heterochronic parabionts (Fig. 3b-d and Supplementary  Fig. 11b) . As a control, no changes in neurogenesis were detected between young WT and young Tap1 −/− isochronic parabionts (Supplementary Fig. 12 ).
Lastly, we investigated the potential benefit of reducing endogenous B2m expression on age-related cognitive decline. We assessed hippocampal-dependent learning and memory in young (3 months) and aged (17 months) B2m-knockout (B2m −/− ) and WT control mice using RAWM and contextual fear conditioning. In young animals, we observed no difference in spatial learning and memory between B2m −/− and WT controls during RAWM training or testing (Fig. 4) . Aged B2m −/− mice showed enhanced spatial learning capacity during RAWM training, as well as enhanced learning and memory for platform location during testing as compared to WT controls (Fig. 4c) . Animals in each age group showed no differences in swim speed regardless of genotype (Supplementary Fig. 13 ). During fear conditioning training, all mice exhibited similar baseline freezing regardless of genotype ( Supplementary Fig. 13b,e) . Additionally, no difference in freezing was observed in young B2m −/− and WT mice during either contextual (Fig. 4b) or cued fear conditioning (Supplementary Fig. 13c ) paradigms. However, aged B2m −/− mice demonstrated significantly increased freezing in contextual (Fig. 4d) , but not cued (Supplementary Fig. 13f) npg Subsequently, we investigated whether the absence of endogenous B2m could also counteract age-related declines in adult neurogenesis. We examined changes in neurogenesis in young (3 months) and aged (17 months) B2m −/− mice and their WT littermates by immunohistochemical analysis. In young animals the absence of endogenous B2m expression had no effect on the number of DCX-positive newly born neurons (Fig. 4e,f) or BrdU-positive proliferating cells (Supplementary Fig. 14a ). However, in aged B2m −/− mice we observed an increase in the number of DCX-positive (Fig. 4e,g ) and BrdU-positive (Supplementary Fig. 14b ) cells compared those observed in WT littermates. Subsequently, we assessed neuronal differentiation and survival in B2m −/− mice using a long-term BrdU incorporation paradigm, in which mature differentiated neurons express both BrdU and the neuronal marker NeuN (Fig. 4h) . Young B2m −/− mice showed no differences in neuronal differentiation (Fig. 4i) , whereas aged B2m −/− mice showed a significant increase compared to that seen in age-matched WT littermates (Fig. 4j) . No differences were detectable in astrocyte differentiation at any age, as quantified by the percentage of cells expressing BrdU and glial fibrillary acidic protein (GFAP) markers (Supplementary Fig. 14c-e) .
B2M, in concert with MHC I molecules, has also been shown to have a unique involvement in the CNS 14, [16] [17] [18] [19] [20] , with previous studies implicating a protective effect of abrogating MHC I expression in brain injury models such as those modeling stroke 35 . Our study elucidates a previously unrecognized role for B2M in the progression of age-related impairments in both cognitive and regenerative processes. Moreover, our study implicates surface MHC I expression in mediating, in part, the negative effects of B2M and heterochronic parabiosis. Notably, human genome-wide association studies (GWASs) have linked the MHC locus on chromosome 6p21 with degenerative diseases of aging, further suggesting an active role for these molecules in age-dependent impairments 36 . It should be noted that, at present, our data does not distinguish between the effects of MHC I expression at the systemic level versus the local level. Therefore, it is important to investigate how the more than 50 MHC I molecules 17 may alter cognitive and regenerative function in the aging brain through both canonical immune and non-canonical neurogenic regulation of processes including neurogenesis and synaptic plasticity. Nevertheless, our data provide mechanistic insights into how aging-related changes in the systemic environment drive impairments locally in the aged brain, and they highlight the involvement of B2M and MHC I molecules in this process. From a translational perspective, our data raise the possibility that age-related cognitive and regenerative dysfunction observed during aging could be ameliorated by therapies targeting B2M in old age.
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npg ONLINE METHOds
Animal models. The following mouse lines were used: C57BL/6 (The Jackson Laboratory), C57BL/6 aged mice (National Institutes of Aging), β2-microglobulin (B2m −/− ) mutant mice and transporter associated with antigen processing 1 (Tap1 −/− ) mutant mice (The Jackson Laboratory). All studies were done in male mice. The numbers of mice used to result in statistically significant differences was calculated using standard power calculations with α = 0.05 and a power of 0.8. We used an online tool (http://www.stat.uiowa.edu/~rlenth/ Power/index.html) to calculate power and sample size on the basis of experience with the respective tests, variability of the assays and inter-individual differences within groups. Mice were housed under specific pathogen-free conditions under a 12-h light-dark cycle and all animal handling and use was in accordance with institutional guidelines approved by the University of California San Francisco Institutional Animal Care and Use Committee (IACUC) and the VA Palo Alto Committee on Animal Research.
Parabiosis. Parabiosis surgery followed previously described procedures 6, 7 .
Mirror-image incisions at the left and right flanks were made through the skin, and shorter incisions were made through the abdominal wall. The peritoneal openings of the adjacent parabionts were sutured together. Elbow and knee joints from each parabiont were sutured together and the skin of each mouse was stapled (9-mm Autoclip, Clay Adams) to the skin of the adjacent parabiont. Each mouse was injected subcutaneously with Baytril antibiotic and Buprenex as directed for pain and monitored during recovery. For overall health and maintenance behavior, several recovery characteristics were analyzed at various times after surgery, including paired weights and grooming behavior.
Stereotaxic injections. Animals were placed in a stereotaxic frame and anesthetized with 2% isoflurane (2 liters/min oxygen flow rate) delivered through an anesthesia nose cone. Ophthalmic eye ointment (Puralube Vet Ointment, Dechra) was applied to the cornea to prevent desiccation during surgery. The area around the incision was trimmed. Solutions were injected bilaterally into the DG of the dorsal hippocampi using the following coordinates: (from bregma) anterior = −2 mm, lateral = 1.5 mm, (from skull surface) height = −2. 1 mm. A 2-µl volume was injected stereotaxically over 10 min (injection speed: 0.20 µl/min) using a 5-µl 26s-gauge Hamilton syringe. To limit reflux along the injection track, the needle was maintained in situ for 8 min, slowly pulled out halfway and kept in position for an additional 2 min. The skin was closed using silk suture. Each mouse was injected subcutaneously with the analgesic Buprenex. Mice were singly housed and monitored during recovery.
B2M administration. Carrier-free purified human β2-microglobulin (Lee Biosolutions) was dissolved in PBS and administered systemically (100 µg/kg) via intraorbital injections in young (3 months) WT mice, or stereotaxically (0.50 ul; 0.1 µg/ul) into the DG of the hippocampus in young (3 months) wild type and Tap1 −/− mice. For histological analysis, B2M and vehicle were administered into contralateral DG of the same animal. For behavioral analysis, B2M or vehicle were administered bilaterally into the DG and mice were allowed to recover for 6 or 30 d before cognitive testing. Immunohistochemistry. Tissue processing and immunohistochemistry was performed on free-floating sections according to standard published techniques 6 . Briefly, mice were anesthetized with 400 mg/kg chloral hydrate (Sigma-Aldrich) and transcardially perfused with 0.9% saline. Brains were removed and fixed in phosphate-buffered 4% paraformaldehyde, pH 7.4, at 4 °C for 48 h before they were sunk through 30% sucrose for cryoprotection. Brains were then sectioned coronally at 40 µm with a cryomicrotome (Leica Camera, Inc.) and stored in cryoprotective medium. Primary antibodies were: goat anti-DCX (1:500; Santa Cruz Biotechnology; sc-8066, clone: C-18), rat anti-BrdU ( Western blot analysis. Mouse hippocampi were dissected after perfusion of animals, snap frozen and lysed in RIPA lysis buffer (500 mM Tris, pH 7.4, 150 mM NaCl, 0.5% sodium deoxycholate, 1% NP-40, 0.1% SDS, and complete protease inhibitors; Roche). Tissue lysates were mixed with 4× NuPage LDS loading buffer (Invitrogen) and loaded on a 4-12% SDS polyacrylamide gradient gel (Invitrogen) and subsequently transferred onto a nitrocellulose membrane. The blots were blocked in 5% milk in TBST and incubated with rabbit anti-actin (1:5,000, Sigma; A5060) and rabbit anti-B2M (1:2500, Abcam; ab75853; clone: EP2978Y). Horseradish peroxidaseconjugated secondary antibodies (1:5,000, GE Healthcare; NA934) and an enhanced chemiluminescence (ECL) kit (GE Healthcare/Amersham Pharmacia Biotech) were used to detect protein signals. Multiple exposures were taken to select images within the dynamic range of the film (GE Healthcare Amersham HyperfilmTM ECL). Selected films were scanned (300 d.p.i. resolution) and quantified using ImageJ software (Version 1.46k). Actin bands were used for normalization.
Cell culture assays. Mouse neural progenitor cells were isolated from C57BL/6 mice or Dcx-reporter mice 37 as previously described 6, 38 . Brains from postnatal animals (1 d old) were dissected to remove olfactory bulbs, cortex, cerebellum and brainstem. After removing superficial blood vessels hippocampi were finely minced with a scalpel, digested for 30 min at 37 °C in DMEM medium containing 2.5U/ml papain (Worthington Biochemicals), 1U/ml dispase II (Boeringher Mannheim), and 250U/ml DNase I (Worthington Biochemicals), and then mechanically dissociated. Neural stem cell/progenitors (NPCs) were purified using a 65% Percoll gradient and plated on uncoated tissue culture dishes at a density of 10 5 cells per cm 2 . NPCs were cultured under standard conditions for 48 h in Neurobasal A medium supplemented with penicillin (100 U/ml), streptomycin (100 mg/ml), 2 mM l-glutamine, serum-free B27 supplement without vitamin A (Sigma-Aldrich), bFGF (20ng/ml) and epidermal growth factor (EGF; 20 ng/ml). Carrier-free forms of human recombinant B2M (Lee Biosolutions) were dissolved in PBS and added to cell cultures under self-renewal conditions every other day after cell plating. For proliferation BrdU incorporation was measured using a cell proliferation assay system that uses a peroxidase-coupled anti-BrdU antibody together with a color substrate for detection (Fisher) . For bioluminescence assays DCX-luciferase activity was measured using a luciferase assay system (Promega). Differentiation was assessed by immunocytochemistry using mouse anti-MAP2 (1:1,000, Sigma; M9942; clone: HM-2) and rabbit anti-GFAP (1:500, DAKO; Z0334) antibodies. Cytotoxicity was measured by lactate dehydrogenase (LDH) detection using a Pierce LDH cytotoxicity assay system (Life Technologies).
npg Contextual fear conditioning. In this task, mice learned to associate the environmental context (fear conditioning chamber) with an aversive stimulus (mild foot shock; unconditioned stimulus, US) enabling testing for hippocampaldependent contextual fear conditioning. As contextual fear conditioning is hippocampus and amygdala dependent, the mild foot shock was paired with a light and tone cue (conditioned stimulus, CS) in order to also assess amygdala-dependent cued fear conditioning. Conditioned fear was displayed as freezing behavior. Specific training parameters are as follows: tone duration is 30 s; level is 70 dB, 2 kHz; shock duration is 2 s; intensity is 0.6 mA. This intensity is not painful and can easily be tolerated but will generate an unpleasant feeling. More specifically, on day 1 each mouse was placed in a fear-conditioning chamber and allowed to explore for 2 min before delivery of a 30-s tone (70 dB) ending with a 2-s foot shock (0.6 mA). Two minutes later, a second CS-US pair was delivered. On day 2, each mouse was first placed in the fear-conditioning chamber containing the same exact context, but with no CS or foot shock. Freezing was analyzed for 1-3 min. One hour later, the mice were placed in a new context containing a different odor, cleaning solution, floor texture, chamber walls and shape. Animals were allowed to explore for 2 min before being re-exposed to the CS. Freezing was analyzed for 1-3 min. Freezing was measured using a FreezeScan video tracking system and software (Cleversys, Inc).
Radial arm water maze. Spatial learning and memory was assessed using the radial arm water maze (RAWM) paradigm according to the protocol described by Alamed et al. 39 . In this task the goal arm location containing a platform remains constant throughout the training and testing phase, while the start arm is changed during each trial. On day 1 during the training phase, mice are trained for 15 trails, with trials alternating between a visible and hidden platform. On day 2 during the testing phase, mice are tested for 15 trials with a hidden platform. Entry into an incorrect arm is scored as an error, and errors are averaged over training blocks (three consecutive trials). Investigators were blinded to genotype and treatment when scoring.
Plasma collection and proteomic analysis. Mouse blood was collected into EDTA coated tubes via tail vein bleed, mandibular vein bleed, or intracardial bleed at time of sacrifice. EDTA plasma was generated by centrifugation at 1,000g of freshly collected blood and aliquots were stored at −80 °C until use. Human plasma and CSF samples were obtained from the University of Washington School of Medicine; Veterans Affairs Northwest Network Mental Illness Research, Education, and Clinical Center; Oregon Health Science University; and University of California San Diego. Subjects were chosen on the basis of standardized inclusion and exclusion criteria as previously described 6, 40, 41 and outlined in Supplementary Table 1 . Informed consent was obtained from human subjects according to the institutional review board guidelines at the respective centers. The plasma concentrations of cytokines and signaling molecules were measured in human and mouse plasma samples using standard antibody-based multiplex immunoassays (Luminex) by RulesBased Medicine Inc., a fee-for-service provider. All Luminex measurements where obtained in a blinded fashion. All assays were developed and validated to Clinical Laboratory Standards Institute (formerly NCCLS) guidelines on the basis of the principles of immunoassay as described by the manufacturers.
Data and statistical analyses. All experiments were randomized and blinded by an independent researcher before pharmacological treatment or assessment of genetic mouse models. Researchers remained blinded throughout histological, biochemical and behavioral assessments. Groups were un-blinded at the end of each experiment upon statistical analysis. Data are expressed as mean ± s.e.m. The distribution of data in each set of experiments was tested for normality using D' Agostino-Pearson omnibus test or Shapiro-Wilk test. No significant differences in variance between groups were detected using an F test. Statistical analysis was performed with Prism 5.0 software (GraphPad Software). Means between two groups were compared with two-tailed, unpaired Student's t-test.
Comparisons of means from multiple groups with each other or against one control group were analyzed with one-way ANOVA followed by appropriate post hoc tests (indicated in figure legends).
